Literature DB >> 11071680

Antibodies and resistance to natural HIV infection.

G J Nabel1, N J Sullivan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11071680     DOI： 10.1056/NEJM200010263431711

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases.

Authors:  V G Hemming
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

2.  Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design.

Authors:  Ralph Pantophlet; Ian A Wilson; Dennis R Burton
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis.

Authors:  Ralph Pantophlet; Rowena O Aguilar-Sino; Terri Wrin; Lisa A Cavacini; Dennis R Burton
Journal:  Virology       Date:  2007-04-06       Impact factor: 3.616

4.  Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.

Authors:  Ralph Pantophlet; Erica Ollmann Saphire; Pascal Poignard; Paul W H I Parren; Ian A Wilson; Dennis R Burton
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.

Authors:  John R Mascola; Mark G Lewis; Thomas C VanCott; Gabriela Stiegler; Hermann Katinger; Michael Seaman; Kristin Beaudry; Dan H Barouch; Birgit Korioth-Schmitz; Georgia Krivulka; Anna Sambor; Brent Welcher; Daniel C Douek; David C Montefiori; John W Shiver; Pascal Poignard; Dennis R Burton; Norman L Letvin
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 6.  HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies.

Authors:  Nyasha Chin'ombe; Vurayai Ruhanya
Journal:  Pan Afr Med J       Date:  2015-04-20

Review 7.  Current situation in the development of a preventive HIV vaccine.

Authors:  José Alcamí; Joan Joseph Munné; María Angeles Muñoz-Fernández; Mariano Esteban
Journal:  Enferm Infecc Microbiol Clin       Date:  2005-07       Impact factor: 1.731
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.